# Invesco CurrencyShares Euro Trust: financial statements, quarterly

FXE · NYSE · CIK 1328598 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fxe.md) · [Financials](/companies/fxe/financials.md) · [Filings](/companies/fxe/filings.md) · [Insiders](/companies/fxe/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fxe/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [1,459](/filings/0000950170-24-122597.md) | [1,543 d](/filings/0000950170-25-027270.md) | [1,424](/filings/0000950170-25-067217.md) | [1,262](/filings/0000950170-25-105145.md) | [1,118](/filings/0001193125-25-270311.md) | [933 d](/filings/0001193125-26-083564.md) | [746](/filings/0001193125-26-209717.md) | [1,562](/filings/0001193125-26-338695.md) | [1,524](/filings/0001193125-25-270311.md) | [1,253 d](/filings/0001193125-26-083564.md) | [1,260](/filings/0001193125-26-209717.md) | [1,217](/filings/0001193125-26-338695.md) |
| Interest expense | $k | not reported | not reported | [0.0](/filings/0000950170-24-054974.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [0.0 d](/filings/0000950170-23-060479.md) | [0.0 d](/filings/0000950170-24-019061.md) | [0.0](/filings/0000950170-24-054974.md) | [0.0 d](/filings/0000950170-24-092104.md) | [0.0 d](/filings/0000950170-24-122597.md) | [0.0 d](/filings/0000950170-25-027270.md) | [0.0](/filings/0000950170-25-067217.md) | [0.0 d](/filings/0000950170-25-105145.md) | [0.0 d](/filings/0001193125-25-270311.md) | [0.0 d](/filings/0001193125-26-083564.md) | [0.0](/filings/0001193125-26-209717.md) | [0.0 d](/filings/0001193125-26-338695.md) |
| Net income | $k | [1,218](/filings/0000950170-24-122597.md) | [1,317 d](/filings/0000950170-25-027270.md) | [1,216](/filings/0000950170-25-067217.md) | [1,075](/filings/0000950170-25-105145.md) | [940](/filings/0001193125-25-270311.md) | [759 d](/filings/0001193125-26-083564.md) | [575](/filings/0001193125-26-209717.md) | [1,081](/filings/0001193125-26-338695.md) | [976](/filings/0001193125-25-270311.md) | [804 d](/filings/0001193125-26-083564.md) | [819](/filings/0001193125-26-209717.md) | [792](/filings/0001193125-26-338695.md) |
| Diluted EPS | $ per share | [0.51](/filings/0000950170-24-122597.md) | not reported | [0.58](/filings/0000950170-25-067217.md) | [0.58](/filings/0000950170-25-105145.md) | [0.54](/filings/0001193125-25-270311.md) | not reported | [0.32](/filings/0001193125-26-209717.md) | [0.23](/filings/0001193125-26-338695.md) | [0.19](/filings/0001193125-25-270311.md) | not reported | [0.20](/filings/0001193125-26-209717.md) | [0.20](/filings/0001193125-26-338695.md) |
| Basic EPS | $ per share | [0.51](/filings/0000950170-24-122597.md) | not reported | [0.58](/filings/0000950170-25-067217.md) | [0.58](/filings/0000950170-25-105145.md) | [0.54](/filings/0001193125-25-270311.md) | not reported | [0.32](/filings/0001193125-26-209717.md) | [0.23](/filings/0001193125-26-338695.md) | [0.19](/filings/0001193125-25-270311.md) | not reported | [0.20](/filings/0001193125-26-209717.md) | [0.20](/filings/0001193125-26-338695.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [230](/filings/0000950170-23-060479.md) | [219](/filings/0000950170-25-027270.md) | [199](/filings/0000950170-24-054974.md) | [173](/filings/0000950170-24-092104.md) | [190](/filings/0000950170-24-122597.md) | [167](/filings/0001193125-26-083564.md) | [234](/filings/0000950170-25-067217.md) | [579](/filings/0000950170-25-105145.md) | [504](/filings/0001193125-25-270311.md) | [423](/filings/0001193125-26-338695.md) | [462](/filings/0001193125-26-209717.md) | [374](/filings/0001193125-26-338695.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [230](/filings/0000950170-23-060479.md) | [220](/filings/0000950170-25-027270.md) | [200](/filings/0000950170-24-054974.md) | [173](/filings/0000950170-24-092104.md) | [191](/filings/0000950170-24-122597.md) | [167](/filings/0001193125-26-083564.md) | [235](/filings/0000950170-25-067217.md) | [580](/filings/0000950170-25-105145.md) | [505](/filings/0001193125-25-270311.md) | [429](/filings/0001193125-26-338695.md) | [463](/filings/0001193125-26-209717.md) | [375](/filings/0001193125-26-338695.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $m | [0.1](/filings/0000950170-23-060479.md) | [0.2](/filings/0000950170-25-027270.md) | [0.5](/filings/0000950170-24-054974.md) | [0.1](/filings/0000950170-24-092104.md) | [0.1](/filings/0000950170-24-122597.md) | [0.1](/filings/0001193125-26-083564.md) | [0.1](/filings/0000950170-25-067217.md) | [0.2](/filings/0000950170-25-105145.md) | [0.2](/filings/0001193125-25-270311.md) | [6.0](/filings/0001193125-26-338695.md) | [0.2](/filings/0001193125-26-209717.md) | [0.2](/filings/0001193125-26-338695.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: not reported
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,188 d](/filings/0000950170-24-122597.md) | [1,155 d](/filings/0000950170-25-027270.md) | [716](/filings/0000950170-25-067217.md) | [1,835 d](/filings/0000950170-25-105145.md) | [957 d](/filings/0001193125-25-270311.md) | [837 d](/filings/0001193125-26-083564.md) | [596](/filings/0001193125-26-209717.md) | [931 d](/filings/0001193125-26-338695.md) | [1,025 d](/filings/0001193125-25-270311.md) | [854 d](/filings/0001193125-26-083564.md) | [810](/filings/0001193125-26-209717.md) | [792 d](/filings/0001193125-26-338695.md) |
| Dividends paid | $k | [1,178](/filings/0000950170-24-122597.md) | [1,277 d](/filings/0000950170-25-027270.md) | [1,219](/filings/0000950170-25-067217.md) | [1,111](/filings/0000950170-25-105145.md) | [947](/filings/0001193125-25-270311.md) | [834 d](/filings/0001193125-26-083564.md) | [596](/filings/0001193125-26-209717.md) | [1,102](/filings/0001193125-26-338695.md) | [1,018](/filings/0001193125-25-270311.md) | [822 d](/filings/0001193125-26-083564.md) | [825](/filings/0001193125-26-209717.md) | [809](/filings/0001193125-26-338695.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [3,556](/filings/0000950170-23-060479.md) | [2,906](/filings/0000950170-24-054974.md) | [2,813](/filings/0000950170-24-092104.md) | [2,371](/filings/0000950170-24-122597.md) | [2,080](/filings/0000950170-25-067217.md) | [1,865](/filings/0000950170-25-105145.md) | [1,747](/filings/0001193125-25-270311.md) | [1,799](/filings/0001193125-26-209717.md) | [4,659](/filings/0001193125-26-338695.md) | [5,023](/filings/0001193125-25-270311.md) | [4,164](/filings/0001193125-26-209717.md) | [3,921](/filings/0001193125-26-338695.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,550,000 at 2026-06-30, from the cover of the [10-Q filed 2026-08-07](/filings/0001193125-26-338695.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. No prices; not investment advice.